J-Pharma Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
18
- Stock Symbol
-
520A
- Share Price
-
$1.98
- (As of Friday Closing)
J-Pharma General Information
Description
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
Contact Information
Website
www.j-pharma.comCorporate Office
- VORT Hamamatsucho II, 8th Floor
- 1-10-11 Hamamatsucho, Minato-ku
- Tokyo, Minato-ku 105-0013
- Japan
Corporate Office
- VORT Hamamatsucho II, 8th Floor
- 1-10-11 Hamamatsucho, Minato-ku
- Tokyo, Minato-ku 105-0013
- Japan
J-Pharma Timeline
J-Pharma Stock Performance
As of 20-Nov-2026, J-Pharma’s stock price is $1.98. Its current market cap is $35.9M with 18.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.98 | $2.04 | $1.60 - $5.10 | $35.9M | 18.1M | 393K |
J-Pharma Financials Summary
As of 31-Mar-2026, J-Pharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 66,453 | 66,453 | ||
| Revenue | 0 | 0 | ||
| EBITDA | (9,822) | (11,413) | ||
| Net Income | (9,830) | (11,436) | ||
| Total Assets | 29,785 | 29,785 | 19,090 | 7,977 |
| Total Debt | 0 | 0 | 0 | 0 |
J-Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
J-Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
J-Pharma Comparisons
Industry
Financing
Details
J-Pharma Competitors (75)
One of J-Pharma’s 75 competitors is Arcturus Therapeutics Holdings, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings | Formerly VC-backed | San Diego, CA | ||||
| Transgene | Corporation | Illkirch-Graffenstaden, France | ||||
| Alaunos Therapeutics | Formerly VC-backed | Fort Lauderdale, FL | ||||
| TME Pharma | Formerly VC-backed | Berlin, Germany | ||||
| iBio | Corporation | San Diego, CA |
J-Pharma Patents
J-Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026132464-A | Cholangitis treatment | Pending | 05-Feb-2025 | ||
| EP-4653014-A1 | Biliary tract cancer treatment agent | Pending | 16-Jan-2023 | ||
| WO-2024154717-A1 | Biliary tract cancer treatment agent | Inactive | 16-Jan-2023 | ||
| US-20250041281-A1 | Method of treating biliary tract cancer | Pending | 16-Jan-2023 | ||
| WO-2022102687-A1 | Therapeutic agent for cancer | Inactive | 11-Nov-2020 |
J-Pharma Signals
J-Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
J-Pharma FAQs
-
When was J-Pharma founded?
J-Pharma was founded in 2005.
-
Where is J-Pharma headquartered?
J-Pharma is headquartered in Tokyo, Japan.
-
What is the size of J-Pharma?
J-Pharma has 18 total employees.
-
What industry is J-Pharma in?
J-Pharma’s primary industry is Drug Discovery.
-
Is J-Pharma a private or public company?
J-Pharma is a Public company.
-
What is J-Pharma’s stock symbol?
The ticker symbol for J-Pharma is 520A.
-
What is the current stock price of J-Pharma?
As of 20-Nov-2026 the stock price of J-Pharma is $1.98.
-
What is the current market cap of J-Pharma?
The current market capitalization of J-Pharma is $35.9M.
-
Who are J-Pharma’s competitors?
Arcturus Therapeutics Holdings, Transgene, Alaunos Therapeutics, TME Pharma, and iBio are some of the 75 competitors of J-Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process